NCT03532282

Brief Summary

This project aims to compare the effectiveness and implementation potential of two primary care friendly approaches to delivering an effective non-pharmacological intervention - cognitive behavioral therapy - for insomnia to middle aged and older adults.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
388

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 1, 2018

Completed
21 days until next milestone

First Posted

Study publicly available on registry

May 22, 2018

Completed
9 months until next milestone

Study Start

First participant enrolled

February 1, 2019

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 12, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 12, 2023

Completed
1.9 years until next milestone

Results Posted

Study results publicly available

December 19, 2024

Completed
Last Updated

December 19, 2024

Status Verified

December 1, 2024

Enrollment Period

3.9 years

First QC Date

May 1, 2018

Results QC Date

December 9, 2024

Last Update Submit

December 17, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Insomnia Severity Index (ISI)

    The ISI is an empirically validated 7-item questionnaire, with each item rated on a 0 to 4 scale. The score is the sum of the 7 items. scores range between 0 and 28 (higher score corresponds with greater insomnia severity), with 10 as a cutoff score for identifying individuals in the community who are likely to meet criteria for insomnia disorder and 8 as a cutoff for defining remission.

    at baseline and at months 2, 4, 6, 9, & 12

  • Use of Prescription Sleep Medication

    The average number of minimal effective doses of prescription sleep medications taken; A greater number means that the person was taking number of minimal effective doses of prescription sleep medications, with a value of 0 meaning that the person is not taking any prescription sleep medication.

    at baseline and at months 2, 4, 6, 9, & 12

Secondary Outcomes (2)

  • Patient-Reported Outcomes Measurement Information System (PROMIS) - Sleep Related Impairment Questionnaire

    at baseline and at months 2, 4, 6, 9, & 12

  • PHQ-4 (The 4 Item Patient Health Questionnaire For Anxiety and Depression)

    at baseline and at months 2, 4, 6, 9, & 12

Study Arms (2)

ONLINE ONLY

ACTIVE COMPARATOR

Online cognitive behavioral therapy for insomnia

Behavioral: ONLINE ONLY

STEPPED CARE

EXPERIMENTAL

Cognitive behavioral therapy for insomnia online or therapist-led or sequentially both

Behavioral: STEPPED CARE

Interventions

ONLINE ONLYBEHAVIORAL

Access to an online cognitive behavioral therapy for insomnia

ONLINE ONLY
STEPPED CAREBEHAVIORAL

A two step treatment that starts with either an online or therapist led cognitive behavioral therapy for insomnia, depending on a decision algorithm (checklist). Those with insufficient progress to the online treatment after 8 weeks are switched to a therapist-led treatment

STEPPED CARE

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • insomnia disorder

You may not qualify if:

  • Unable to be consented in English without an interpreter
  • In poor physical or mental that limits capacity to participate in study treatment (e.g., Mini-Mental State Examination score \< 25)
  • Unable to use the internet
  • Study physician determines participation is not medically advised for any reason

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University

Palo Alto, California, 94305, United States

Location

Related Publications (3)

  • Manber R, Gumport NB, Tully IA, Kim JP, Kim B, Simpson N, Rosas LG, Zulman DM, Goldhaber-Fiebert JD, Rangel E, Dietch JR, Tutek J, Palaniappan L. Effects of a Triage Checklist to optimize insomnia treatment outcomes and reduce hypnotic use: the RCT of the effectiveness of stepped-care sleep therapy in general practice study. Sleep. 2025 Jan 13;48(1):zsae182. doi: 10.1093/sleep/zsae182.

  • Tully IA, Kim JP, Simpson N, Palaniappan L, Tutek J, Gumport NB, Dietch JR, Manber R. Beliefs about prescription sleep medications and interest in reducing hypnotic use: an examination of middle-aged and older adults with insomnia disorder. J Clin Sleep Med. 2023 Jul 1;19(7):1247-1257. doi: 10.5664/jcsm.10552.

  • Manber R, Tully IA, Palaniappan L, Kim JP, Simpson N, Zulman DM, Goldhaber-Fiebert JD, Rangel E, Dietch JR, Rosas LG. RCT of the effectiveness of stepped-care sleep therapy in general practice: The RESTING study protocol. Contemp Clin Trials. 2022 May;116:106749. doi: 10.1016/j.cct.2022.106749. Epub 2022 Mar 30.

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Results Point of Contact

Title
Rachel Manber, PhD
Organization
Stanford University

Study Officials

  • Rachel Manber, PhD

    Stanford University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Participants are asked to refrain from mentioning any information about the treatment they receive when interacting with the investigator or outcomes assessors
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 1, 2018

First Posted

May 22, 2018

Study Start

February 1, 2019

Primary Completion

January 12, 2023

Study Completion

January 12, 2023

Last Updated

December 19, 2024

Results First Posted

December 19, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

The researchers will share fully de-identified data on: the two primary outcomes, allocation to arm, and demographic.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Data will become available 2 years after the publication of the results pertaining to the primary aims. Data will be available for 2 years after its release
Access Criteria
Data will be shared only with investigators who have a clear and rigorous analytic plan and who sign a data use agreement with Stanford University.

Locations